Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients
Faisal A. Alzahrani, Islam M. Saadeldin, Abrar Ahmad, et al.
Stem Cells International (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications
Md Nurul Huda, Md Nafiujjaman, Isaac G. Deaguero, et al.
ACS Biomaterials Science & Engineering (2021) Vol. 7, Iss. 6, pp. 2106-2149
Open Access | Times Cited: 166
Biomaterials for Tissue Engineering Applications and Current Updates in the Field: A Comprehensive Review
Alaa Emad Eldeeb, Salwa Salah, Nermeen A. Elkasabgy
AAPS PharmSciTech (2022) Vol. 23, Iss. 7
Open Access | Times Cited: 80
Biogenesis and delivery of extracellular vesicles: harnessing the power of EVs for diagnostics and therapeutics
Jivin Yu, Saba Sane, Ji-Eun Kim, et al.
Frontiers in Molecular Biosciences (2024) Vol. 10
Open Access | Times Cited: 28
Unveiling the promise: Exosomes as game‐changers in anti‐infective therapy
Vivek P. Chavda, Guanghong Luo, Rajashri Bezbaruah, et al.
Exploration (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 19
Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey
Magaly Villena-Tejada, Ingrid Vera-Ferchau, Anahí Cardona-Rivero, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0257165-e0257165
Open Access | Times Cited: 90
Advances in Extracellular Vesicle Nanotechnology for Precision Theranostics
Qian Wu, Siyuan Fu, Hanyang Xiao, et al.
Advanced Science (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 54
A Comprehensive Insight into the Role of Exosomes in Viral Infection: Dual Faces Bearing Different Functions
Mabroka H. Saad, Raied Badierah, Elrashdy M. Redwan, et al.
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1405-1405
Open Access | Times Cited: 54
Strong Inhibitory Activity and Action Modes of Synthetic Maslinic Acid Derivative on Highly Pathogenic Coronaviruses: COVID-19 Drug Candidate
Raya Soltane, Amani Chrouda, Ahmed Mostafa, et al.
Pathogens (2021) Vol. 10, Iss. 5, pp. 623-623
Open Access | Times Cited: 52
Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19
Dipak Kumar, Sadaf Jahan, Andleeb Khan, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 7, pp. 3417-3434
Open Access | Times Cited: 48
Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19
Zaki F. Aref, Shamardan Ezzeldin S. Bazeed, Mohammed H. Hassan, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 4063-4072
Open Access | Times Cited: 45
Recent Progress in Nanotechnology for COVID-19 Prevention, Diagnostics and Treatment
Yousef Rasmi, Kouass Saloua, Mahdieh Nemati, et al.
Nanomaterials (2021) Vol. 11, Iss. 7, pp. 1788-1788
Open Access | Times Cited: 45
A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention
Jatin Machhi, Farah Shahjin, Srijanee Das, et al.
Journal of Neuroimmune Pharmacology (2021) Vol. 16, Iss. 2, pp. 270-288
Open Access | Times Cited: 44
Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects
Mai Abdelgawad, Nourhan Saied Bakry, Ahmed A. Farghali, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Extracellular Vesicles for Disease Treatment
Fangyan Wang, Jiayin Feng, Anqi Jin, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3303-3337
Open Access
Conventional and Nonconventional Sources of Exosomes–Isolation Methods and Influence on Their Downstream Biomedical Application
Olga Janoušková, Regina Herma, Alena Semerádtová, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 25
COVID-19 inflammation and implications in drug delivery
Makhloufi Zoulikha, Feifei Huang, Zhenfeng Wu, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 260-274
Open Access | Times Cited: 23
Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation
Eleonore Fröhlich
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 232-232
Open Access | Times Cited: 31
Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells
Wanich Suksatan, Supat Chupradit, Alexei Valerievich Yumashev, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108217-108217
Open Access | Times Cited: 29
Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study
Meruyert Dauletova, Hafsan Hafsan, Negah Mahhengam, et al.
Clinical Immunology (2021) Vol. 226, pp. 108712-108712
Open Access | Times Cited: 27
Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era
Birbal Singh, Gorakh Mal, Vinod Verma, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses
Sin Man Lam, Xun Huang, Guanghou Shui
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 8, pp. 554-568
Open Access | Times Cited: 18
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
Pawan Kumar Raghav, Zoya Mann, Simran Kaur Ahluwalia, et al.
Journal of Pharmacological Sciences (2023) Vol. 152, Iss. 1, pp. 1-21
Open Access | Times Cited: 11
Critical role of nitric oxide in impeding COVID-19 transmission and prevention: a promising possibility
Rajalakshmi Rajendran, Anjana Chathambath, Abdullah G. Al‐Sehemi, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 26, pp. 38657-38672
Open Access | Times Cited: 17
Exosomes in COVID‐19 infection: Focus on role in diagnosis, pathogenesis, immunity, and clinical trials
Alhanouf Aljuhani, Omniah Albalawi, Rahaf Albalawi, et al.
Cell Biology International (2023) Vol. 47, Iss. 6, pp. 1049-1067
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top